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Abstract
Background: Malaria case management is one of the key strategies to control malaria. Various studies have
demonstrated the feasibility of home management of malaria (HMM). However, data on the costs and effectiveness
of artemisinin-based combination therapy (ACT) and rapid diagnostic tests via HMM is limited.
Method: Cost-effectiveness of home management versus health facility-based management of uncomplicated
malaria in two rural districts in Zambia was analysed from a providers’ perspective. The sample included 16
community health workers (CHWs) and 15 health facilities. The outcome measure was the cost per case
appropriately diagnosed and treated. Costs of scaling-up HMM nationwide were estimated based on the CHW
utilisation rates observed in the study.
Results: HMM was more cost effective than facility-based management of uncomplicated malaria. The cost per
case correctly diagnosed and treated was USD 4.22 for HMM and USD 6.12 for facility level. Utilization and
adherence to diagnostic and treatment guidelines was higher in HMM than at a health facility.
Conclusion: HMM using ACT and RDTs was more efficient at appropriately diagnosing and treating malaria than
the health facility level. Scaling up this intervention requires significant investments.
Background
Malaria case management is one of the key strategies to
control malaria [1]. The adoption of new effective artemi-
sinin-based combination therapy (ACT) in Africa has
began to show positive health impacts in terms of malaria
morbidity and mortality reduction [1,2] with some coun-
tries contemplating malaria elimination [1]. Additionally,
the introduction of rapid diagnostic tests (RDTs) for
malaria has changed the approach to malaria diagnosis.
Presumptive treatment of fevers as malaria is no longer
encouraged because it leads to misdiagnosis of the disease
and irrational drug use [3]. With the adoption of RDTs in
routine health services, malaria confirmation is no longer
a preserve of areas with laboratory services. RDTs are
increasingly gaining attention for their practical use given
the limitations of scaling up microscopy services [4].
RDT diagnosis of malaria has been said to be rapid and
requiring less inputs than microscopy and no specialized
personnel is required to perform the tests [5,6]. This has
potentially improved patient access to diagnosis services,
especially in peripheral health centres [6].
In spite of all these achievements, access to prompt and
effective case management still remains a challenge. It is
for this reason that WHO recommended the adoption of
the home management of malaria (HMM). HMM has
been shown to be feasible and acceptable [7]. Addition-
ally various approaches for scaling up HMM include
pharmacists, villages volunteers or shopkeepers [8]. The
choice of strategy depends on the health system context.
Malaria in Zambia is a major cause of visitation and
hospitalization. In 2009, approximately three million
cases and 2,000 deaths were recorded from health
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provided free of charge in the public sector both in
rural and urban areas up to health facility level. In
urban areas, some private health facilities do provide
malaria and other health services to a less extent. How-
ever, in rural areas, the people mostly depend solely on
the available public health facilities. Sometimes, the
facilities are in distant locations, which create geographi-
cal access barriers. In areas where the health facilities
exist, the lack of adequate human resources sometimes
leads to delays and long queues.
Community health workers (CHWs) form part of the
health system in the rural areas. Their main mandate,
until recently, was in health education. However, due to
the growing demand for patient care, plans are under-
way to scale up HMM with ACT and RDTs using
CHWs. CHWs are able to interpret instructions cor-
rectly on how to use RDTs [10] and they can safely pre-
scribe ACT.
A study was carried to evaluate the cost and effective-
ness of managing uncomplicated malaria with ACT and
RDTs using CHWs in comparison with the health facil-
ity model.
Methods
Study design
This was a cost-effectiveness evaluation of the manage-
ment of uncomplicated malaria using the HMM strategy
versus health facility-based management following the
standard malaria treatment guidelines for Zambia. The
provider perspective was used because malaria services
a r eo f f e r e df r e eo fc h a r g et ot h eu s e rs i n c em a l a r i ai s
part of the basic health care package in Zambia. The
basic health care package is a package of basic health
services for common diseases, which are provided free
of charge in government (public) owned health facilities.
The government is the main health provider in the
country. The main outcome measure was the proportion
of uncomplicated malaria cases correctly diagnosed and
treated according to national malaria case management
guidelines.
Study population and duration
The study included all age groups who sought care
through the CHWs and the health facility in the study
sites between January and December 2009. The study
period covered both high and low transmission seasons.
Both strategies involved use of diagnostic testing and
treatment with ACT. In Chongwe district, nine CHWs
with a total catchment area of 16,079 were included in
the study, while in Kalomo seven CHWs surrounded by
18,279 people were included in the study. The CHWs
were selected based on prior IMCI training and involve-
ment in malaria at the time of the study. In both
districts, the villages served by CHWs are far from the
health facilities but the patients have a choice whether
to use the CHWs or the health facility as the first point
of care. The health facilities included in the study were
those in the vicinity of the selected CHWs in each dis-
trict; eight in Chongwe and seven in Kalomo districts
repsectively.
Study sites
The study was conducted in Chongwe and Kalomo dis-
trict as part of a main study to evaluate the feasibility
and effectiveness of the management of uncomplicated
malaria using ACT and RDTs in the home management
of malaria via CHWs. Chongwe district is located in
Lusaka Province, an area which is typically rural and
experiences moderate malaria transmission. The district
is estimated to have a population of about 157,664 inha-
bitants, with 26 health facilities and an annual malaria
incidence estimated at 130/1,000 population in 2008 [9].
Kalomo district on the other hand is situated in the
southern Province, with a population of about 181,379
inhabitants. The district has 24 health facilities and the
annual malaria incidence was estimated to at 82/1,000
population [9]. Both districts are implementing the user
fees removal policy (thus patients are not expected to
pay any fees for the basic health care package).
Description of the interventions under comparison
Home management of malaria delivered by CHWs
This strategy involved training the already existing
CHWs on the use of RDTs and ACT in the management
of uncomplicated malaria. Further training was provided
on the management of biological wastes and sharp
objects, such as lancets. Additional orientation on drug
and logistics management was given. The CHWs were
then provided with malaria registers and medical supplies
and re-deployed to their areas of operation. Any fever
patient who reported to the CHWs was supposed to be
subjected to a finger prick to ascertain malaria status.
Complicated malaria cases and non-malaria febrile cases
were referred to the nearest health facility for further
management. All services were provided free of charge,
in line with the country policy on health care financing.
Pre-packaged AL was the ACT of choice and HRP-II
RDTs were used according to the country stocks. The
management of the stocks of AL, RDTs and other con-
sumables was the responsibility of the CHWs under the
supervision of the health facility as per routine operation
guidelines. Replenishment of drugs and logistics were
made by the health facility once the CHW made a
request using a specially designed logistics form for
RDTs and ACT. Each CHW was provided a new bicycle
for transport (this is the standard form of transport for
CHWs in Zambia). The study team conducted monthly
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registers.
Health facility management of malaria delivered by
professional health workers
Under this strategy (standard practice), a clinical officer,
environmental health technician or nurse is in charge of
managing health facilities at any of the selected 15 health
facilities. The health facilities were selected on the basis
of being in the locality of the CHWs included in the
HMM strategy described above. These health workers
were prior to the study already trained in malaria case
management using the new guidelines (confirmation plus
u s eo fA C T ) .A tt h eh e a l t hf a c i l i t yt w oo p t i o n sa r ea v a i l -
able for diagnosis: microscopy or RDTs. The patient flow
has already been described elsewhere [11]. The health
workers received additional orientation (refresher) on
new treatment guidelines, supervision of CHWs and
logistics management. Pre-packaged AL was the ACT of
choice and HRP-II RDTs were used according to the
country stocks. Other anti-malarials at health facility
level included SP for IPT and quinine for severe malaria.
Chloroquine is no longer part of the anti-malarial list for
health facilities in Zambia. The health facility level man-
ages both complicated and uncomplicated malaria using
a tiered referral system. Additional referrals from CHWs
were also managed accordingly. Malaria diagnosis and
treatment data was recorded in the out-patient depart-
ment (OPD) malaria register. The study team carried out
monthly supervision to ensure data completeness for the
purposes of the study.
Data collection
Malaria registers were used by both the health facility
personnel and CHWs. All the patients who were mana-
ged during the study period were recorded in these reg-
isters. The method of diagnosis and type of treatment
was also recorded. Secondary data from published litera-
ture and official Ministry of Health records were used
for costing information as shown in Table 1.
The ingredient approach combined with step-down
approach to costing was used to estimate average costs
p e ry e a ri nl i n ew i t hm e t h o d sf o rc o s t i n gh e a l t hp r o -
grammes [12]. Step-down costing was used in personnel,
administrative and some capital cost centres. Inventories
on capital and recurrent costs related to malaria diagno-
sis and treatment at facility and community level were
made. Procurement reports, receipts, action plans and
market prices were used to measure and value the
resources used.
Capital resources (i.e. items which have a useful life of
more than one year) were annualized based on the
replacement value, its estimated useful life and the offi-
cial discount rate used in Zambia (5%). Capital costs at
health facility level included equipment, vehicles and
buildings. The allocation of capital costs to malaria diag-
nosis was performed by estimating an allocation factor
per facility based on malaria OPD utilization. Other
facility level costs have already been described [11].
Recurrent costs
Personnel costs were measured based on number and
categories of each type of staff (nurse, clinical officer,
medical doctor, community health worker, etc) and
their respective annual salaries. These were then allo-
cated based on the utilization of facilities by suspected
malaria patients. Shared recurrent costs for supplies and
utilities were valued and allocated based on the facility
utilization factor. However, costs unique to malaria
(such as cost of the diagnostic technique) were fully
allocated as such. The parameters and assumptions used
in the analysis of costs and outcomes are summarized in
the Table 1.
Outcome measure
The outcome measure was the proportion of cases
appropriately diagnosed and treated. Appropriate diag-
nosis was malaria confirmation by either RDT or micro-
scopy. Appropriate treatment included: AL first line
treatment for uncomplicated malaria for all age groups
except for children weighing 5 kg or less in whom SP is
prescribed; Quinine for complicated malaria and no
anti-malarials in cases with a negative test outcome.
Average cost effectiveness and incremental cost
effectiveness analysis
Malaria related costs were identified and analysed. Cost
profiles included, drug costs, RDT costs, other consum-
ables, transport, personnel time and other relevant inputs
for both arms. The total cost of diagnosis was estimated
using the number of cases tested by RDT or microscopy
multiplied by the unit cost of diagnosis for each strategy.
The average cost per case tested was determined by divid-
ing the total costs of diagnosis by number of cases tested
by RDT and microscopy. The average cost per case treated
was determined by dividing the total costs of treatments
by number of cases treated under each strategy.
Cost effectiveness analysis
The main outcome measure was the number of malaria
cases appropriately diagnosed and treated according to
national case management guidelines..
Thus cost-effectiveness = Total cost/number of
malaria cases appropriately diagnosed and treated under
each alternative.
Incremental cost-effectiveness
The incremental cost per additional case appropriately
diagnosed and treated was calculated based on the
changes in the costs and effects of moving from the
strategy that costs less per patient diagnosed and treated
to the next alternative.
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priately diagnosed and treated.
Ethical consideration
Ethical approval was obtained from the Tropical Disease
Research Ethics Committee. Further clearance was
obtained from the Permanent Secretary of the Ministry
of Health.
Results
The average utilization of CHWs by the target popula-
tion in the two districts was estimated at 29% (35% in
Chongwe and 23% in Kalomo district). The utilization
rate was estimated using the catchment population of
the CHWs in each district as the denominator and the
number of visits to the CHW as the numerator. The
catchment population under consideration was 16,079
in Chongwe and 18,279 in Kalomo. The crude parasite
prevalence was 24% and 26% among CHW and health
facility visits respectively. These figures are within the
national estimates of 27% from the national population
based parasitological surveys [13].
At community level no microscopy testing was done,
all the cases were diagnosed using RDT while at health
facility level either microscopy or RDT was used. This is
in line with national policy of introducing only RDTs at
community level but health facilities can use whichever
test is available at the time of a patient visit. The pro-
p o r t i o no fp a t i e n t si nw h o mac o n f i r m a t o r yt e s tw a s
performed was higher at community (97%) than at
health facility level (56%) as shown in Table 2.
T h ea v e r a g ec o s tp e rc a s ea p p r o p r i a t e l yt e s t e dw a s
higher at health facility than at community level. This is
because personnel and capital costs are higher at health
facility level. The current HMM strategy uses CHWs
who have been working on voluntary basis and thus are
not salaried. However, the costs of RDTs and ACT are
the same at HF and HMM level because they use the
same national procurement and distribution system.
Treatment
More negative cases were treated with anti-malarial at
health facility than at community level. The proportion
of cases correctly treated was higher at community than
at health facility level as shown in Table 3. 30% negative
on test were treated with anti-malarial at health facility.
Among the cases testing positive at facility level 52%
were treated with AL, 33% with SP and 10% with qui-
nine. Additionally, 5% of the cases testing positive at
health facility level were not prescribed an anti-malarial.
The incremental cost-effectiveness ratio was USD 4.18
per case appropriately diagnosed and treated. This is the
cost required to increase the number of cases
Table 1 Parameter Assumptions and Data Sources
Description Assumption Source
Exchange Rate
(annual average for 2009)
1USD = ZMK4900 http://www.aonda.com
Discount rate 5% MOH Planning Unit
Overhead costs 15%
(Of district recurrent
expenditure)
District Health Office (DHO)
Personnel costs Gross earnings
(Taken from central level)
MOH/DHO
Cost of drug AL = 1.00 USD
SP = 0.18 USD
Quinine = 0.84 USD
NMCC, (weighted average cost per person/course including storage and
distribution costs).
Cost/test RDT = 0.6USD
Microscopy = 1.00 USD
NMCC (excludes personnel and capital costs).
Sensitivity (RDTs) 95.4% [19,20].
Prevalence (national) 27.0% [13]
Annual average malaria prevalence
at OPD
Kalomo = 26%
Chongwe = 22%
[9,21]
Table 2 Average cost per case appropriately diagnosed
Variable HMM Health
facility
Number of cases 9,847 53450
Number tested with RDT 9,552. 24587
Number tested with microscopy 0 5345
Number tested clinically 295.00 23518
Proportion of fever cases in whom test is
used
97% 56.00%
Total tested with either RDT or microscopy 9,552.00 29932
Total cost of diagnostic test (USD) 38,112.48 159387.90
Proportion of cases appropriately tested 97% 56%
Average cost per case appropriately tested
(USD)
3.99 5.33
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H M Mw i t hA C Ta n dR D T sa tc o m m u n i t yl e v e li nt h e
rural areas where it is applicable).
Estimation of costs of scaling up HMM with ACT and
RDTs in rural parts of Zambia
The assumptions for population were based on the 2010
census figures for Zambia (CSO Monthly Bulletin 2011).
The census figures indicates that of the 13,046,508 per-
sons in Zambia, about 7,978,274 (61%) were in rural
areas. According to this study, it was estimated that 35%
and 23% of catchment population utilized the CHWs
for malaria in Chongwe and Kalomo respectively. These
figures were used to estimate the number of CHWs
required to scale up HMM to meet the target popula-
tion in the rural areas. The estimates were made for a
ratio of 1CHW per 500 persons in the rural areas. In
the scenario where the average 29% of the rural popula-
tion utilized the CHWs, the scale-up costs were esti-
mated to be about USD 9,763,811.72. This represents
about a quarter of the annual national malaria budget.
Scenarios were also made for made for 20% and 35% uti-
lization as shown in Tables 4 and 5. The costs of scaling
up were USD 6.7 million for 20% and USD11.8 million for
35% utilization. These costs may be reduced by increasing
the CHW to patient ratio from 1:500 to 1:1,000.
Discussion
The community approach could provide an effective and
cost-effective way of increasing access to prompt and
effective case management. HMM with RDTs and ACTs
c a nb es c a l e du pe v e ni nr e s o u r c ec o n s t r a i n ts e t t i n g s ,
such as Zambia where there is also a looming human
resource crisis. It also provides more evidence on the
economical and health benefits of introducing ACT and
RDTs in the HMM strategy.
It is important to point out that better practices were
reported in the HMM model than at health facility level.
CHWs adhered to case management guidelines and this
consequently resulted in more cases appropriately diag-
nosed and treated than at facility level. The findings also
bring out an improtant aspect that the availability of
commodities for malaria control should not be the only
bottleneck to be improved upon in an effort to deliver
effective case management. Traning and mentoring is
k e yt oe n s u r et h a th e a t hw o r k e r sa d h e r et og o o dc a s e
management so that they utilize the available tools cor-
rectly. Otherwise the cost-effectiveness of ACT and
RDTs are negated by the poor practice of health work-
ers [14]. Non adherence to malaria diagnostic test result
has already been documented to be a problem among
health workers in Zambia [15,16]. The training model
f o rC H W su s e di nt h i ss t u d yc a na l s ob es c a l e du pt o
large scale health facility level so as to introduce good
practices at health facility level. This has the potential to
improve not only malaria case management but overall
Table 3 Cost per case appropriately diagnosed and treated
Variable HMM Health facility
Number positive for malaria 2,318.00 7782
Parasite prevalence 24% 26%
Number treated with AL 2,282.00 4047
Number treated with SP 16.00 2568
Number referred for quinine 20.00 778
Negative for malaria treated with anti-malarial 13.00 6645
Negative for malaria not treated with anti-malarial 7,516.00 15505
Proportion of cases appropriately treated 100% 43%
Total cost of anti-malarial treatment (USD) 2,303.22 29,845.76
Total number of cases correctly treated 9,834.00 23,287
Cost per case appropriately treated (USD) 0.23 1.28
Cost per case appropriately diagnosed and treated (USD) 4.22 6.61
Incremental effectiveness (HF to HMM) 0.57
Incremental costs (HF to HMM 2.38
ICER 4.18
Table 4 Estimated costs of scaling up HMM assuming
29% of the rural communities utilize CHWs
1CHW:500
Rural Population for Zambia (CSO 2011) 7,978,274.00
Expected @ 29% (average of 35%&23%) observed in
study
2,313,699.46
Cost per case appropriately diagnosed and treated 4.22
Scale-up costs (USD) 9,763,811.72
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used in a health facility study in one district and similar
good case management practices were attained [2]. This
is because not prescribing anti-malarials to non-malaria
fevers, provides an opportunity for patients to be
invstiagated for another cause of illness. HMM with
ACT and RDTs is thus not only economical but it can
potentially lead to better health outcomes. In Kenya, a
study demonstrated that shopkeeper trainings improved
the proportion of cases taking appropriate anti-malarial
doses [8].
The cost per case appropriately diagnosed and treated
through HMM is lower than cost which have been
reported by other studies for scaling up HMM using
various strategies. In Ghana, IPTc via community based
voulunteers found the least cost effective method to be
about USD 8.19. HMM without diagnosis has been
demonstrated not to have better outcomes than the
facility level [17]. This seems to emphasize the need to
adopt the strategy of including the diagnosis component
in HMM as has been recommended by other research-
ers [8]. RDTs are attractive and easy to scale up at com-
munity level than microscopy because less capital
invetsments are required [5,6]. Furthermore, in Zambia,
it has been demonstarted that RDTs are cost effective in
the management of malaria at facility level [11]. The
negative effects of false negatives are minimized by use
of HRP-II based RDTs which have been shown to over-
estimate the burden of malaria by 10% [18].
The scale-up costs found in this study are substantial
at the beginning of the programme, but the mainte-
nance costs are feasible and can be managed by district
level management. This is because in the case of Zam-
bia, both ACT and RDTs are centrally procured and
thus the HMM strategy does not require its own logis-
tics and management system. The CHWs are also
already part of the health care system and do receive
baseline training in health programmes. This level of
community involvement provides a vehicle for the deliv-
ery of HMM by adding effective tools such as RDTs and
ACT instead of treating malaria patients with SP based
on fever. Thus other malaria programmes contemplating
HMM should consider the health system context and
review existing channels which can be used to have an
effective HMM strategy.
The cost per patient appropriately diagnosed could
change upwards if CHWs were to be salaried, however,
the level of increase would be determined by the volume
of non-malaria services that CHWs may be allowed to
offer if salaried. Additionally, capital investments such as
screening rooms or booths for CHWs to work in may
also positively change the unit costs found in the HMM
strategy. However, none of these would render the
HMM strategy to be less effective.
Further areas for research include the impact of HMM
strategy on the outcomes of non-malaria fevers and the
effectiveness of the training model proposed in this
study in a multicentre study.
Conclusion
HMM was more cost-effective for management of
uncomplicated malaria in rural areas than the standard
of care at health facility level (USD4.22 versus
USD6.61). Utilization and adherence to both diagnostic
and treatment guidelines was higher in HMM strategy
than at health facility level. Scale-up costs for HMM
would depend on the expected utilisation and the
desired patient to provider ratio.
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20% and 35% of the rural communities utilize CHWs
1CHW:500
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